Skip to main content

Publications

505 publications

Active

6 grants
  • MPI
    Project 1: Increasing therapeutic efficacy in IDH-mutant AML
    NCI · 2021–2031 · via NIH RePORTER
    P50CA254838-06
  • MPI
    Clonal hematopoiesis as a targetable mechanism of resistance to therapy in thyroid cancer.
    NCI · 2026–2031 · via NIH RePORTER
    R01CA303958-01A1
  • PI
    Synergistic role of signaling and epigenetics in leukemic transformation
    NCI · 2017–2030 · via NIH RePORTER
    R35CA197594-11
  • MPI
    Project 1: Molecular Pathogenesis and Therapy of Myelofibrosis
    NCI · 2006–2028 · via NIH RePORTER
    P01CA108671-18
  • PI
    Assessing the Interplay Between Inflammatory Signaling and Epigenetic Dysregulation in Age-associated Clonal Hematopoiesis and Leukemia Initiation
    NIA · 2021–2027 · via NIH RePORTER
    U01AG077925-05
  • MPI
    ECOG-ACRIN Integrated Leukemia Translational Science Center (LTSC)
    NCI · 2019–2026 · via NIH RePORTER
    UG1CA233332-06S1
Completed grants (10)
  • MPI
    Role of TET2 mutations in malignant transformation and acute myeloid leukemia
    NCI · 2013–2025 · via NIH RePORTER
    R01CA173636-10
  • PI
    The cohesin complex as a tumor suppressor in myeloid leukemia
    NCI · 2017–2022 · via NIH RePORTER
    R01CA216421-05
  • PI
    Single-cell cytokine analysis to detect and measure human myelofibrosis
    NIDDK · 2014–2020 · via NIH RePORTER
    U01DK104331-05
  • MPI
    ECOG-ACRIN INTEGRATED LEUKEMIA TRANSLATIONAL RESEARCH CENTER
    NCI · 2014–2019 · via NIH RePORTER
    U10CA180827-05
  • PI
    Single cell cytokine analysis of circulating malignant hematopoietic cells
    NCI · 2015–2019 · via NIH RePORTER
    R33CA196411-03
  • PI
    Genetic Dissection of Acute Myeloid Leukemia.
    NCI · 2014–2018 · via NIH RePORTER
    R01CA169784-05
  • PI
    Molecular Pathogenesis and Therapy of ET and PMF
    NCI · 2010–2017 · via NIH RePORTER
    R01CA151949-06
  • PI
    Dynamics of Tumor Stem Cells in Cancer Initiation, Therapy, and Resistance
    NCI · 2008–2014 · via NIH RePORTER
    R01CA138234-06
  • PI
    Molecular genetic analysis of tyrosine kinases in myeloproliferative disorders
    NHLBI · 2006–2011 · via NIH RePORTER
    K08HL082677-06
  • PI
    High Throughput Screen for JAK2V617F Mutant Selective Inhibitors
    NIDA · 2008–2010 · via NIH RePORTER
    R03DA026206-01